Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine and Ofatumumab in elderly DLBCL patients
NCT01626352Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Oct 2012
- Primary completion
- Sep 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in diffuse large B-cell lymphoma (DLBCL), sponsored by SCRI Development Innovations. Started Oct 2012; status: completed.
02
Drugs
ofatumumab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01626352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01626352.